Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease

McGuire, 2003, Anticancer antifolates: current status and future directions, Curr. Pharm. Des., 9, 2593, 10.2174/1381612033453712 Nzila, 2005, Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy, Trends Parasitol., 21, 292, 10.1016/j.pt.2005.04.002 Hopkins, 1889, Note on yellow pigments in butterflies, Nature, 40, 335 Kaufman, 1963, The structure of the phenylalanine-hydroxylation cofactor, Proc. Natl. Acad. Sci. USA, 50, 1085, 10.1073/pnas.50.6.1085 Nagatsu, 1964, Conversion of l-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissues, Biochem. Biophys. Res. Commun., 14, 543, 10.1016/0006-291X(64)90266-9 Brenneman, 1965, Characteristics of the hepatic phenylalanine–hydroxylating system in newborn rats, J. Biol. Chem., 240, 3617, 10.1016/S0021-9258(18)97188-7 Haavik, 1987, Isolation and characterization of tetrahydropterin oxidation products generated in the tyrosine 3-monooxygenase (tyrosine hydroxylase) reaction, Eur. J. Biochem., 168, 21, 10.1111/j.1432-1033.1987.tb13381.x Rebrin, 1995, Catalytic characterization of 4a-hydroxytetrahydropterin dehydratase, Biochemistry, 34, 5801, 10.1021/bi00017a011 Kwon, 1989, Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages, J. Biol. Chem., 264, 20496, 10.1016/S0021-9258(19)47089-0 Tayeh, 1989, Macrophage oxidation of l-arginine to nitric oxide, nitrite, and nitrate tetrahydrobiopterin is required as a cofactor, J. Biol. Chem., 264, 19654, 10.1016/S0021-9258(19)47163-9 Tanaka, 1989, Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein, Biochem. Pharmacol., 38, 1985, 10.1016/0006-2952(89)90498-X Thony, 2000, Tetrahydrobiopterin biosynthesis, regeneration and functions, Biochem. J., 347 Pt 1, 1, 10.1042/0264-6021:3470001 Kojima, 1995, Antioxidative activity of 5,6,7,8-tetrahydrobiopterin and its inhibitory effect on paraquat-induced cell toxicity in cultured rat hepatocytes, Free Radic. Res., 23, 419, 10.3109/10715769509065263 Shimizu, 1998, Protective effects of tetrahydrobiopterin against nitric oxide-induced endothelial cell death, Life Sci., 63, 1585, 10.1016/S0024-3205(98)00427-5 Werner-Felmayer, 2002, Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects, Curr. Drug Metab., 3, 159, 10.2174/1389200024605073 Burg, 1968, The biosynthesis of folic acid. 8. Purification and properties of the enzyme that catalyzes the production of formate from carbon atom 8 of guanosine triphosphate, J. Biol. Chem., 243, 2349, 10.1016/S0021-9258(18)93481-2 Gross, 2000, An essential cofactor of nitric oxide synthase with an elusive role, 167 Shimizu, 2003, Hydrogen peroxide stimulates tetrahydrobiopterin synthesis through the induction of GTP-cyclohydrolase I and increases nitric oxide synthase activity in vascular endothelial cells, Free Radic. Biol. Med., 34, 1343, 10.1016/S0891-5849(03)00172-2 Hattori, 1993, GTP cyclohydrolase I mRNA is induced by LPS in vascular smooth muscle: characterization, sequence and relationship to nitric oxide synthase, Biochem. Biophys. Res. Commun., 195, 435, 10.1006/bbrc.1993.2062 Gross, 1993, Tetrahydrobiopterin synthesis is induced by LPS in vascular smooth muscle and is rate-limiting for nitric oxide production, Adv. Exp. Med. Biol., 338, 295, 10.1007/978-1-4615-2960-6_61 Milstien, 1996, Bonner, Purification and cloning of the GTP cyclohydrolase I feedback regulatory protein, GFRP, J. Biol. Chem., 271, 19743, 10.1074/jbc.271.33.19743 Yoneyama, 1997, GTP cyclohydrolase I feedback regulatory protein is a pentamer of identical subunits. Purification, cDNA cloning, and bacterial expression, J. Biol. Chem., 272, 9690, 10.1074/jbc.272.15.9690 Giovanelli, 1991, Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine, Proc. Natl. Acad. Sci. USA, 88, 7091, 10.1073/pnas.88.16.7091 Raman, 1998, Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center, Cell, 95, 939, 10.1016/S0092-8674(00)81718-3 Fischmann, 1999, Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation, Nat. Struct. Biol., 6, 233, 10.1038/6675 Crane, 1998, Structure of nitric oxide synthase oxygenase dimer with pterin and substrate, Science, 279, 2121, 10.1126/science.279.5359.2121 Vasquez-Vivar, 1998, Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors, Proc. Natl. Acad. Sci. USA, 95, 9220, 10.1073/pnas.95.16.9220 Liu, 1996, Binding sites of nitric oxide synthases, Methods Enzymol., 268, 311, 10.1016/S0076-6879(96)68033-1 Klatt, 1994, Inhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation, J. Biol. Chem., 269, 1674, 10.1016/S0021-9258(17)42080-1 Gorren, 1996, Tetrahydrobiopterin-free neuronal nitric oxide synthase: evidence for two identical highly anticooperative pteridine binding sites, Biochemistry, 35, 16735, 10.1021/bi961931j Ghosh, 1995, Macrophage NO synthase: characterization of isolated oxygenase and reductase domains reveals a head-to-head subunit interaction, Biochemistry, 34, 801, 10.1021/bi00003a013 Rodriguez-Crespo, 1996, Endothelial nitric-oxide synthase. Expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation, J. Biol. Chem., 271, 11462, 10.1074/jbc.271.19.11462 Klatt, 1995, Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer, Embo. J., 14, 3687, 10.1002/j.1460-2075.1995.tb00038.x Vasquez-Vivar, 2000, Generation of superoxide from nitric oxide synthase, FEBS Lett., 481, 305, 10.1016/S0014-5793(00)02001-9 Presta, 1998, Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase, Biochemistry, 37, 298, 10.1021/bi971944c Riethmuller, 1999, Activation of neuronal nitric-oxide synthase by the 5-methyl analog of tetrahydrobiopterin Functional evidence against reductive oxygen activation by the pterin cofactor, J. Biol. Chem., 274, 16047, 10.1074/jbc.274.23.16047 Hevel, 1992, Macrophage nitric oxide synthase: relationship between enzyme-bound tetrahydrobiopterin and synthase activity, Biochemistry, 31, 7160, 10.1021/bi00146a019 Werner, 1996, Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase, Biochem. J., 320, 193, 10.1042/bj3200193 Bec, 1998, Reaction of neuronal nitric-oxide synthase with oxygen at low temperature. Evidence for reductive activation of the oxy-ferrous complex by tetrahydrobiopterin, J. Biol. Chem., 273, 13502, 10.1074/jbc.273.22.13502 Crabtree, 2008, 8-Dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs superoxide production by eNOS, Am. J. Physiol. Heart Circ. Physiol., 294, H1530, 10.1152/ajpheart.00823.2007 Stroes, 1998, Origin of superoxide production by endothelial nitric oxide synthase, FEBS Lett., 438, 161, 10.1016/S0014-5793(98)01292-7 Vasquez-Vivar, 2003, The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications, Free Radic. Res., 37, 121, 10.1080/1071576021000040655 Vasquez-Vivar, 2004 Crabtree, 2009, Quantitative regulation of intracellular endothelial nitric oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: Insights from cells with tet-regulated GTP cyclohydrolase I expression, J. Biol. Chem., 284, 1136, 10.1074/jbc.M805403200 Vasquez-Vivar, 2002, The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study, Biochem. J., 362, 733, 10.1042/0264-6021:3620733 Cosentino, 1997, High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells, Circulation, 96, 25, 10.1161/01.CIR.96.1.25 Guzik, 2002, Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase, Circulation, 105, 1656, 10.1161/01.CIR.0000012748.58444.08 Heitzer, 1996, Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL, Circulation, 93, 1346, 10.1161/01.CIR.93.7.1346 Landmesser, 2003, Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension, J. Clin. Invest., 111, 1201, 10.1172/JCI200314172 Maier, 2000, Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease, J. Cardiovasc. Pharmacol., 35, 173, 10.1097/00005344-200002000-00001 Bendall, 2005, Stoichiometric relationships between endothelial tetrahydrobiopterin, eNOS activity and eNOS coupling in vivo: Insights from transgenic mice with endothelial-targeted GTPCH and eNOS over-expression, Circ. Res., 97, 864, 10.1161/01.RES.0000187447.03525.72 Ozaki, 2002, Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice, J. Clin. Invest., 110, 331, 10.1172/JCI0215215 Hauer, 1993, Heizmann, Phenylalanine hydroxylase-stimulating protein/pterin-4 alpha-carbinolamine dehydratase from rat and human liver. Purification, characterization, and complete amino acid sequence, J. Biol. Chem., 268, 4828, 10.1016/S0021-9258(18)53471-2 Davis, 1992, Distribution of 4a-hydroxytetrahydropterin dehydratase in rat tissues. Comparison with the aromatic amino acid hydroxylases, FEBS Lett., 302, 73, 10.1016/0014-5793(92)80288-R Hurshman, 1999, Formation of a pterin radical in the reaction of the heme domain of inducible nitric oxide synthase with oxygen, Biochemistry, 38, 15689, 10.1021/bi992026c Vasquez-Vivar, 2001, Reaction of tetrahydrobiopterin with superoxide: EPR-kinetic analysis and characterization of the pteridine radical, Free Radic. Biol. Med., 31, 975, 10.1016/S0891-5849(01)00680-3 Curtius, 1985, Tetrahydrobiopterin biosynthesis. Studies with specifically labeled (2H)NAD(P)H and 2H2O and of the enzymes involved, Eur. J. Biochem., 148, 413, 10.1111/j.1432-1033.1985.tb08855.x Nichol, 1983, Biosynthesis of tetrahydrobiopterin by de novo and salvage pathways in adrenal medulla extracts, mammalian cell cultures, and rat brain in vivo, Proc. Natl. Acad. Sci. USA, 80, 1546, 10.1073/pnas.80.6.1546 Chalupsky, 2005, Endothelial dihydrofolate reductase: Critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase, Proc. Natl. Acad. Sci. USA, 102, 9056, 10.1073/pnas.0409594102 Crabtree, 2009, Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways, J. Biol. Chem., 284, 28128, 10.1074/jbc.M109.041483 Sugiyama, 2009, Tetrahydrobiopterin recycling a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells, J. Biol. Chem., 284, 12691, 10.1074/jbc.M809295200 Ren, 2008, IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction, Am. J. Physiol. Regul. Integr. Comp. Physiol., 294, R793, 10.1152/ajpregu.00713.2007 Ionova, 2008, Deficient BH4 production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytes, Am. J. Physiol. Heart Circ. Physiol., 295, H2178, 10.1152/ajpheart.00748.2008 Oak, 2007, Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice, Diabetes, 56, 118, 10.2337/db06-0288 Vasquez-Vivar, 2002, Altered tetrahydrobiopterin metabolism in atherosclerosis: implications for use of oxidized tetrahydrobiopterin analogues and thiol antioxidants, Arterioscler. Thromb. Vasc. Biol., 22, 1655, 10.1161/01.ATV.0000029122.79665.D9 Crabtree, 2011, Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency, Free Radic. Biol. Med., 10.1016/j.freeradbiomed.2011.03.010 Matsubara, 1964, On the presence of sepiapterin reductase different from folate and dihydrofolate reductase in chicken liver, Experientia, 20, 574, 10.1007/BF02150303 Gao, 2009, Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability, Am. J. Physiol. Heart Circ. Physiol., 297, H331, 10.1152/ajpheart.00007.2009 Zorzi, 2002, Detection of sepiapterin in CSF of patients with sepiapterin reductase deficiency, Mol. Genet. Metab., 75, 174, 10.1006/mgme.2001.3273 Kaufman, 1991, Some metabolic relationships between biopterin and folate: implications for the “methyl trap hypothesis”, Neurochem. Res., 16, 1031, 10.1007/BF00965847 Yamamoto, 1996, A comparison of sepiapterin and tetrahydrobiopterin uptake by RBL2H3 cells, Pteridines, 7, 154, 10.1515/pteridines.1996.7.4.154 Yamamoto, 1997, Uptake of tetrahydrobiopterin by cells in monolayer cultures of RBL2H3 and PC12 cell lines, 759 Hasegawa, 2000, Ability of RBL2H3 cells to lower environmental tetrahydrobiopterin concentration, Pteridines, 11, 121, 10.1515/pteridines.2000.11.4.121 Hasegawa, 2001, Cells take up BH4 oxidize it and the oxidized biopterin is preferentially released, 205 Sawabe, 2003, Increase in the biopterin pool after tetrahydrobiopterin administration is due to uptake of an oxidation product dihydrobiopterin and conversion to the reduced state, 41 Kobayashi, 1991, J Pharmacol Exp Ther, 256, 773 Kapatos, 1992, Tetrahydrobiopterin turnover in cultured rat sympathetic neurons: developmental profile, pharmacologic sensitivity, and relationship to norepinephrine synthesis, J. Neurochem., 59, 2048, 10.1111/j.1471-4159.1992.tb10093.x Nakanishi, 2005, Increase in tetrahydrobiopterin release from PC12 cells under hypotonic culture conditions is inhibited by HgCl2, Pteridines, 16, 1, 10.1515/pteridines.2005.16.1.1 Sawabe, 2001, Sepiapterin administration raises tissue BH4 levels more efficiently than BH4 supplement in normal mice, 199 Sawabe, 2004, Tetrahydrobiopterin uptake in supplemental administration: elevation of tissue tetrahydrobiopterin in mice following uptake of the exogenously oxidized product 7 8-dihydrobiopterin and subsequent reduction by an anti-folate-sensitive process, J. Pharmacol. Sci., 96, 124, 10.1254/jphs.FP0040280 Sawabe, 2005, Accumulated BH4 in mouse liver caused by administration of either 6R- or 6SBH4 consisted solely of the 6R-diastereomer: evidence of oxidation to BH2 and enzymic reduction, Mol. Genet. Metab., 86 Suppl 1, S145, 10.1016/j.ymgme.2005.06.019 Hasegawa, 1979, Cofactor activity of diastereoisomers of tetrahydrobiopterin, 195 Matsuura, 1980, Studies on biologically active pteridines. III. The absolute configuration at the C-6 chiral center of tetrahydrobiopterin cofactor and related compounds, J. Biochem. (Tokyo), 87, 951, 10.1093/oxfordjournals.jbchem.a132825 Sawabe, 2005, Cellular accumulation of tetrahydrobiopterin following its administration is mediated by two different processes; direct uptake and indirect uptake mediated by a methotrexate-sensitive process, Mol. Genet. Metab., 86 Suppl. 1, S133, 10.1016/j.ymgme.2005.06.020 Fukuda, 2002, Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia, Heart, 87, 264, 10.1136/heart.87.3.264 Heitzer, 2000, Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase, Circ. Res., 86, E36, 10.1161/01.RES.86.2.e36 Heitzer, 2000, Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus, Diabetologia, 43, 1435, 10.1007/s001250051551 Stroes, 1997, Tetrahydrobiopterin restores endothelial function in hypercholesterolemia, J. Clin. Invest., 99, 41, 10.1172/JCI119131 Alp, 2004, Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease, Arterioscler. Thromb Vasc. Biol., 24, 413, 10.1161/01.ATV.0000110785.96039.f6 Katusic, 2001, Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?, Am. J. Physiol. Heart Circ. Physiol., 281, H981, 10.1152/ajpheart.2001.281.3.H981 Zheng, 2003, Gene transfer of human guanosine 5’-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension, Circulation, 108, 1238, 10.1161/01.CIR.0000089082.40285.C3 Alp, 2003, Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression, J. Clin. Invest., 112, 725, 10.1172/JCI17786 Alp, 2004, Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice, Arterioscler. Thromb Vasc. Biol., 24, 445, 10.1161/01.ATV.0000115637.48689.77 Ueda, 2000, Tetrahydrobiopterin restores endothelial function in long-term smokers, J. Am. Coll. Cardiol., 35, 71, 10.1016/S0735-1097(99)00523-9 Setoguchi, 2001, Tetrahydrobiopterin improves endothelial dysfunction in coronary microcirculation in patients without epicardial coronary artery disease, J. Am. Coll. Cardiol., 38, 493, 10.1016/S0735-1097(01)01382-1 Fukuda, 2002, Tetrahydrobiopterin improves coronary endothelial function, but does not prevent coronary spasm in patients with vasospastic angina, Circ. J., 66, 58, 10.1253/circj.66.58 Setoguchi, 2002, Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure, J. Cardiovasc. Pharmacol., 39, 363, 10.1097/00005344-200203000-00007 Ihlemann, 2003, Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects, Am. J. Physiol. Heart Circ. Physiol., 285, H875, 10.1152/ajpheart.00008.2003 Higashi, 2006, Tetrahydrobiopterin improves aging-related impairment of endothelium-dependent vasodilation through increase in nitric oxide production, Atherosclerosis, 186, 390, 10.1016/j.atherosclerosis.2005.07.025 Mayahi, 2007, 6R)-5,6,7,8-tetrahydro-L-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm, Arterioscler. Thromb. Vasc. Biol., 27, 1334, 10.1161/ATVBAHA.107.142257 Eskurza, 2005, Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults, J. Physiol., 568, 1057, 10.1113/jphysiol.2005.092734 Sommer, 2006, Evaluation of tetrahydrobiopterin (BH4) as a potential therapeutic agent to treat erectile dysfunction, Asian J. Androl., 8, 159, 10.1111/j.1745-7262.2006.00122.x Worthley, 2007, Effects of tetrahydrobiopterin on coronary vascular reactivity in atherosclerotic human coronary arteries, Cardiovasc. Res., 76, 539, 10.1016/j.cardiores.2007.07.009 Higashi, 2002, Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals, Am. J. Hypertens., 15, 326, 10.1016/S0895-7061(01)02317-2 Porkert, 2008, Tetrahydrobiopterin a novel antihypertensive therapy, J. Hum. Hypertens., 22, 401, 10.1038/sj.jhh.1002329 Cosentino, 2008, Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia, Heart, 94, 487, 10.1136/hrt.2007.122184 Wyss, 2005, Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia, Eur. J. Nucl. Med. Mol. Imaging, 32, 84, 10.1007/s00259-004-1621-y Nystrom, 2004, Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease, Am. J. Physiol. Endocrinol. Metab., 287, E919, 10.1152/ajpendo.00046.2004